Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patients

Treatment response to omalizumab in patients with refractory chronic spontaneous urticaria

Int J Dermatol.

Syrigos N, Grapsa D, Zande M, Tziotou M, Syrigou E

doi: 10.1111/ijd.13935.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of "Real-world" Evidence

JAMA Dermatol.

Tharp MD, Bernstein JA, Kavati A, Ortiz B, MacDonald K, Denhaerynck K, Abraham I, Lee CS

doi: 10.1001/jamadermatol.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Omalizumab Retreatment and Step-Up in Patients with Chronic Spontaneous Urticaria: OPTIMA Trial

J Allergy Clin Immunol Pract.

Sussman G, Hébert J, Gulliver W, Lynde C, Yang WH, Papp K, Gooderham M, Chambenoit O, Khalil S, DeTakacsy F, Vieira A, Rihakova L

doi: 10.1016/j.jaip.2020.03.022.

Atopic Dermatitis

Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial

JAMA Pediatr.

Chan S, Cornelius V, Cro S, Harper JI, Lack G

doi: 10.1001/jamapediatrics.2019.4476.

Further Publications Dermatology

Response of Peripheral Blood Basophils in Subjects with Chronic Spontaneous Urticaria During Treatment with Omalizumab

J Allergy Clin Immunol

MacGlashan D Jr, Saini S, Schroeder JT

doi: 10.1016/j.jaci.2021.02.039

Autoimmune DiseaseJuvenile Idiopathic Arthritis

Safety of weekly adalimumab in the treatment of juvenile idiopathic arthritis and pediatric chronic uveitis

Clin Rheumatol.

Correll CK, Bullock DR, Cafferty RM, Vehe RK

doi: 10.1007/s10067-017-3890-4.

Efficacy and Safety of Ozenoxacin Cream for Treatment of Adult and Pediatric Patients With Impetigo: A Randomized Clinical Trial

JAMA Dermatol.

Rosen T, Albareda N, Rosenberg N, Alonso FG, Roth S, Zsolt I, Hebert AA

doi: 10.1001/

Further Publications Immunology

Effectiveness and tolerability of personalized omalizumab treatment in patients with chronic inducible urticaria

J Allergy Clin Immunol Pract

Buters TP, van der Velden WAC, Abdisalaam I, van Maaren MS, van Doorn MBA

doi: 10.1016/j.jaip.2021.04.034

Psoriasis

Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in pediatric patients (≥6 to < 12 years of age): efficacy, safety, pharmacokinetic, and biomarker results from the open-label CADMUS Jr study

Br J Dermatol.

Philipp S, Menter A, Nikkels AF, Barber K, Landells I, Eichenfield LF, Song M, Randazzo B, Li S, Hsu MC, Zhu Y, DePrimo S, Paller AS

doi: 10.1111/bjd.19018.

Related content